Menu Close

Category: Daily News

Feds Sue UnitedHealth Twice in One Month

The U.S. Justice Department for the second time in a month sued UnitedHealth Group Inc accusing the nation’s largest health insurer of obtaining over $1 billion from Medicare to which it was not entitled. The complaint, filed in federal court in Los Angeles, came after the Justice Department brought a separate but similar case against UnitedHealth. In both cases, the government intervened in whistleblower lawsuits against UnitedHealth.

The latest complaint came after the Justice Department intervened in a lawsuit brought by former UnitedHealth executive Benjamin Poehling, whose whistleblower case was filed under seal in 2011. In the lawsuit, the Justice Department alleged that UnitedHealth obtained inflated risk adjustment payments based on untruthful and inaccurate information about the health status of patients enrolled in its Medicare Advantage plans.

The case is U.S. ex rel. Benjamin Poehling v. UnitedHealth Group Inc et al, U.S. District Court, Central District of California, No. 16-cv-08697. The lawsuit said UnitedHealth’s conduct damaged the Medicare program by over $1.14 billion from 2011 to 2014. The Justice Department said it is seeking triple damages under the False Claims Act as well as penalties.

Poehling filed his lawsuit under the False Claims Act, which allows whistleblowers to sue companies on the government’s behalf to recover taxpayer money paid out based on fraudulent claims. If successful, whistleblowers receive a percentage of the recovery. A government decision to intervene is typically a major boost to such cases.

Poehling also sued other insurers, claiming that they along with UnitedHealth had defrauded the United States of hundreds of millions – and likely billions – of dollars through claims for payments from Medicare for the elderly. While the Justice Department has not pursued claims against other companies, in March it said it was investigating Centene Corp’s Health Net Inc, Aetna Inc, Cigna Corp’s Bravo Health Inc and Humana Inc.

The Justice Department has also intervened in a related whistleblower lawsuit brought by James Swoben, a former Senior Care Action Network Health Plan employee and a consultant to the risk adjustment industry.

UnitedHealth had no immediate comment. It previously said it rejects the claims in the underlying whistleblower lawsuit and would fight the claims vigorously.

Another County Sues Drugmakers for Opioid Epidemic

A county in New York state has sued Purdue Pharma LP, Johnson & Johnson and other drugmakers, accusing them of engaging in fraudulent marketing that played down the risks of prescription opioid painkillers, leading to a drug epidemic. The lawsuit, which also named units of Teva Pharmaceutical Industries Ltd and Endo International Plc as defendants, was announced by Orange County, New York, which is located in the southeastern part of the state.

Reuters reports that the case, filed in a New York state court is the latest lawsuit by local and state governments seeking to hold drugmakers accountable for a national opioid epidemic. The lawsuit claims the drugmakers through deceptive marketing misrepresented the dangers of long-term opioid use to doctors, pharmacists and patients. Those misrepresentations about drugs like Purdue’s OxyContin and Endo’s Opana ER led Orange County New York to incur health care, criminal justice and other costs related to addiction, the lawsuit said.

Drugmakers also face lawsuits by Santa Clara and Orange counties in California, the city of Chicago and Mississippi over their marketing practices.

Santa Clara and Orange (California) counties filed a case in 2015 in Orange County Superior Court. They alleged that Purdue Pharma, Cephalon, Janssen Pharmaceuticals, Endo Health Solutions and Actavis violated California’s false advertising and unfair competition laws and created a public nuisance. The case was placed on hold in 2015 pending the outcome of FDA investigations that were underway at the time.

Chicago sued Teva Pharmaceuticals, Purdue Pharma Inc. and other drugmakers in 2014, saying they misled doctors and the public about the addictive nature of opiates and pushed prescriptions despite known dangers of addiction. A defense request for a stay order pending FDA investigations was denied in September 2016, and the Chicago case is still active.

Some state attorneys general have started similar investigations. J&J this month said New Jersey’s attorney general had issued a subpoena related to opioid marketing.

Orange County New York, which has a population of about 379,000, said it recorded 943 opioid-related emergency department admissions in 2014 and 44 deaths from overdoses involving opioid pain relievers in 2015.

Orange County New York Executive Steven Neuhaus said in a statement the county has been working with non-profits and doctors to increase awareness to opioid-related problems. “At the same time, we want those responsible to compensate the taxpayers for the public funds the county has had to pay to address opioid addiction,” he said.

The lawsuit also named four physicians as defendants.

J&J in a statement called the allegations “unfounded” and noted its drugs carry U.S. Food and Drug Administration-mandated warnings.

Purdue said it shares officials’ concerns about the opioid crisis and is “committed to working collaboratively to find solutions.”

Endo did not respond to a request for comment. Teva declined to comment.

Opioid drugs, including prescription painkillers and heroin, killed over 33,000 people in the United States in 2015, more than any year on record, the U.S. Centers for Disease Control and Prevention said.

Orange County’s lawsuit is the fourth since August by a New York county seeking to recover costs related to opioid addiction. Several other counties are also considering suing.

Mona Garifias Appointed to CHSWC

The Department of Industrial Relations and the Commission on Health and Safety and Workers’ Compensation (CHSWC) announced that the Senate Rules Committee has appointed Mona Garfias to the Commission as an employer representative. The position does not require Senate confirmation.

The Commission consists of eight members, four representing employers and four from organized labor. The Governor appoints four Commissioners, and the Speaker of the Assembly and the Senate Rules Committee each appoint two members.

Since 1998 Ms. Garfias has been Director of Claims for DMS Facility Services, a large unionized employer in the janitorial industry with over 1800 employees.

She started her career in the insurance industry 27 years ago and held various workers’ compensation claims positions on both the insurance carrier and insurance brokerage side. Ms. Garfias was instrumental in implementing the Ross Pike Memorial Workers’ Compensation Carve-Out & Alternative Dispute Resolution (ADR) program and continues to be involved on a daily basis.

CHSWC, created by the workers’ compensation reform legislation of 1993, is charged with examining the health and safety and workers’ compensation systems in California and recommending administrative or legislative modifications to improve its operations.

Information about CHSWC is available at www.dir.ca.gov/chswc. Information may also be obtained by writing to CHSWC at 1515 Clay Street, 17th floor, Oakland, CA 94612; by calling (510) 622-3959; by faxing a request to 510-286-0499; or by sending an email to chswc@dir.ca.gov.

Liberty Mutual Ends Work Injury Research Center

Liberty Mutual is shutting down its research arm in Hopkinton that for six decades put it at the forefront of workplace injury prevention, prosthetic limb development, and the push for safer car features, including collapsible steering columns.

The company will no longer conduct peer-reviewed research, considered the gold-standard for studies, which extended its reach worldwide. The research influenced occupational safety guidelines that were widely used to prevent injuries in the workplace. According to the story in the Boston Globe, up to 44 employees, mostly scientists and researchers, could be laid off when the company ends the program on June 6.

When Liberty Mutual founded the research facility in 1954 it was one of few organizations studying injuries in the workplace and on the road. But since then many more outlets are researching workplace issues. And the nature of work has changed as well. More people are working remotely or in shared spaces and manufacturing now involves robots doing assembly line work. And John Cusolito, a Liberty Mutual spokesman said that other organizations and universities are better positioned to do that kind of research.

Liberty Mutual will focus its research efforts on partnerships with universities that are involved in workplace studies. The company helps fund work at the Harvard T.H. Chan School of Public Health, the University of Massachusetts Amherst, UMass Lowell, and MIT.

“We will use funds to continue and create partnerships with organizations and specialists that give us the flexibility to tap into research studying the evolving ways that people are living and working,” Cusolito said.

Liberty Mutual was among a handful of insurers that ran their own research centers. The institute focused heavily on workplace injuries – falls, carpal tunnel syndrome, and the impact of repetitive work – because Liberty Mutual began as a workers compensation insurer covering railway, shipbuilding, and tannery workers hurt on the job.

As recently as 2012, Liberty Mutual was the largest workers compensation insurer with $4.2 billion in premiums, according to the Insurance Information Institute, a trade research organization. But by 2015, the most recent data available, Liberty Mutual had fallen to fifth in market share with $2.5 billion in premiums.

Over the years it has expanded into auto and home insurance and other commercial lines. It has also scaled back its workers compensation business, as rising medical costs and state regulations cut into profits.

Tom Leamon, who served as director of the research institute for safety for 16 years until 2006, said its closure is disappointing.

“It was a way to distinguish Liberty in the global marketplace,” Leamon said. “We were the leaders in global occupational safety.”

The research that its scientists conducted – bringing in people to lift containers of different sizes to measure the impact on their bodies, or evaluating the best way to grasp tools such as knives and screwdrivers for long periods – was published in scientific journals and accessible to everybody, including competitors, Leamon said.

Working with MIT in the early 1960s, researchers helped develop the first battery-powered prosthetic elbow, called the Boston Elbow. Holliston-based Liberating Technologies Inc., a manufacturer and distributor of prosthetic devices, started out as a project of Liberty Mutual, until it was spun off as an independent company around 2001.

Liberty Mutual will keep open the Hopkinton facility, where driver training programs and classes for claims adjusters will continue.

Indictment Claims Turlock Physician Defrauded Blue Cross

Turlock dermatologist Basil Hantash M.D., faces charges of health care fraud after seeking payments from insurers allegedly for surgeries that were not performed.

A federal grand jury returned the eight-count indictment Thursday against the 44 year old physician who has been medical director and co-owner of Advanced Skin Institute on Geer Road in Turlock.

According to the indictment, the case involves claims seeking payment for acne surgeries that Hantash submitted to insurance companies between early 2011 and April 2016. An FBI investigation concluded that those patients at Advanced Skin Institute had received only chemical peels, or microdermabrasions, which are cosmetic treatments often not covered by insurers.

The indictment says insurers Anthem Blue Cross and Blue Shield of California paid $220,000 to Advanced Skin Institute for acne surgeries that were not performed.

The Modesto Bee reports that his Attorney Kirk McAllister said the doctor is contesting the charges. “This is a disagreement between the doctor and bean counters at a medical insurance company trying to save money,” McAllister said. “The insurance company has persuaded the government to file these charges.”

In a press release, the Department of Justice said the maximum penalty for the felony charges is 10 years in prison and $2 million in fines.

Prosecutors maintain that chemical peels at the Turlock clinic were primarily done by licensed estheticians, who are not allowed to perform surgeries. The treatments remove outer layers of damaged skin to bring out a healthier-looking appearance.

Insurance companies mostly refuse to pay for chemical peels because they are a cosmetic treatment. Dermatologists are reimbursed, however, for medically necessary acne surgeries, in which a surgical blade is used to cut a lesion and drain fluid.

According to the indictment, Hantash sought $1.2 million in payments on claims for acne surgeries submitted to Anthem Blue Cross during the five-year period. Anthem paid $147,858 on those claims. Blue Shield reimbursed $81,515 for the $645,000 in claims for acne surgeries submitted by Hantash.

The federal government alleges that Hantash and Advanced Skin Institute provided falsified medical records in March 2014 in response to an Anthem Blue Cross audit. “The records falsely claimed that Hantash and (the clinic) had performed acne surgeries on certain patients by using surgical blades. In fact, the patients had only received microdermabrasions or chemical peels,” the indictment says.

If he is convicted, Hantash could forfeit $687,600 that was held in accounts by Vanguard Marketing Corp.

McAllister countered the doctor was involved in a yearlong billing dispute with one insurer and the matter was headed for arbitration. The defense attorney said the practices at Advanced Skin Institute and the billings were appropriate.

A Department of Justice staff member said prosecutors are not commenting further because of the ongoing investigation.

Carrier has Right to “Retroactively” Rescind Policy

When EJ Distribution Corporation applied for workers’ compensation insurance, the application indicated that EJ’s employees did not travel out of state. The online application prepared by its insurance agent described EJ’s operations as “local hauling” and that EJ’s employees did not travel out of state and did not have a radius of travel greater than 200 miles.  Accordingly Southern Insurance issued a workers’ compensation policy beginning on January 1, 2009.

On April 6, 2009, EJ’s employee, David Berrios-Segovia, injured his back while on a trip to Tennessee and filed a workers’ compensation claim on May 13, 2009.

On June 12, 2009, Southern’s attorneys sent a letter to EJ stating that “Southern is rescinding the policy.” The decision to rescind was based on material misrepresentations or the concealment of material facts by EJ in the application for the policy, specifically that its employees did not travel out of state and that its operations did not exceed a radius of travel of 200 miles.

In light of Southern’s position that the policy was rescinded the Uninsured Employers Benefits Trust Fund (UEBTF) was joined as a defendant in Segovia’s workers’ compensation claim.

The coverage issue  was submitted to mandatory arbitration pursuant to Labor Code section 5275, subdivision (a)(1). Southern called an underwriter as a witness who testified that Southern never insured long-haul trucking in its business division. In addition, the underwriter testified that, had Southern known that EJ traveled outside of 200 miles or out of state, Southern would not have issued the policy. The underwriter, however, confirmed that the policy itself, in fact all workers’ compensation policies, did not contain an exclusion based on location.

The arbitrator found: There was “no retroactive rescission” of the policy; Segovia’s claim for his April 6, 2009 injury was covered by the policy; and the policy was prospectively canceled under Insurance Code section 676.8, subdivision (b)(5) as of June 15, 2009, and not before. The arbitrator dismissed UEBTF as a defendant.  Southern’s Petition for Reconsideration by was denied by the WCAB. But the court of appeal reversed in the unpublished case of Southern Ins. Co. v. Workers’ Compensation Appeals Bd.

The opinion noted that Insurance Code Section 676.8 which is entitled Cancellation and Failure to Renew Certain Property Insurance, is specifically limited to workers’ compensation insurance and it addresses only the cancellation of a policy. It does not even inferentially address rescission. But, Section 650 provides that “[w]henever a right to rescind a contract of insurance is given to the insurer by any provision of this part such right may be exercised at any time previous to the commencement of an action on the contract.” Section 650 applies to workers’ compensation insurance policies.

UEBTF’s contention that rescission is precluded because section 676.8 does not provide for protection of the right to rescind a workers’ compensation insurance policy was rejected. UEBTF also contended that once a workers’ compensation claim has been filed, section 650 precludes rescission. However, the Court of Appeal ruled that the filing of a workers’ compensation claim is not the equivalent of an action on the contract.

The appeals board generally agreed that a workers’ compensation insurance policy can be rescinded under the authority of section 650. However, the appeals board contends, and rightly so, that rescission should not be used for the improper purpose of obtaining impermissible modifications to a workers’ compensation insurance policy. But, the answer to the appeals board’s concern is that if rescission is asserted as a defense to the claim in a workers’ compensation proceeding, the appeals board itself can ensure that the rescission is not used as a subterfuge to evade the laws governing workers’ compensation insurance.

There is also the concern over the injured worker who has filed a workers’ compensation claim but is faced with an insurer who has acted to rescind the policy. The answer here is that the insurer cannot be certain that the rescission will be enforced and that the insurer is therefore well advised to avoid drastic decisions about coverage until the validity of the rescission has been adjudged.

Contrary to the arbitrator’s ruling, a workers’ compensation insurance policy may be rescinded. The conclusion is unavoidable that the issue whether Southern’s rescission was legally effective remains factually open and unresolved.The decision of the appeals board affirming the findings and award of the arbitrator is annulled and the matter is remanded to the appeals board for further proceedings consistent with this opinion.

Lancaster Clinic Pays $3 Million in Fraud Case

A Lancaster-based radiation therapy center has paid $3 million to resolve allegations that it submitted fraudulent bills over a nearly 10-year period to three government-run healthcare programs for unsupervised radiation oncology services.

Valley Tumor Medical Group paid $2,865,693 to the United States and $134,307 to the State of California on April 13 to resolve allegations in a “whistleblower” lawsuit that it submitted fraudulent bills to the Medicare, Medi-Cal and TRICARE programs.

The civil action, United States ex rel. Shindler v. Valley Tumor Medical Group, et al., CV 15-2249, was unsealed and dismissed on April 20 by United States District Judge R. Gary Klausner.

From January 3, 2006 through November 13, 2015, Valley Tumor’s radiation therapists allegedly administered radiation oncology treatments at Valley Tumor’s Ridgecrest location to beneficiaries of the three government healthcare programs when no doctor was on-site at the center, which is required by federal regulations. Valley Tumor closed its Ridgecrest location in early 2016.

Valley Tumor was named in a federal “whistleblower” lawsuit filed in 2015 that alleged the company and its doctor-owners knowingly submitted false claims to the Medicare, Medi-Cal and TRICARE programs. The lawsuit was brought by a former Valley Tumor employee under the qui tam – or whistleblower – provisions of the False Claims Act, which allows private citizens to bring suit on behalf of the government and share in any recovery.

The whistleblower, Jared Shindler, received $555,000 from the settlement.

Valley Tumor did not admit liability in settling the lawsuit.

This case was investigated by the U.S. Department of Health and Human Services, Office of Inspector General. The settlement was finalized by Assistant United States Attorney Linda A. Kontos of the Civil Fraud Section.

New JAMA Study Confounds Life Expectancy Estimates

An accurate estimate of the life expectancy of a workers’ compensation claimant is important for setting reserves, making or accepting offers for compromise and release, and certain other calculations such as commutations for attorney fees, or lump sum payments.

One method of estimating life expectancy is to use a one-size-fits all chart or table based upon historical data. This is the method set by California regulations (§10169. Commutation Tables and Instructions) when a commutation of future benefits is ordered by a WCJ. This table is based on the U.S. Decennial Life Tables for 1989-91, a metric that is outdated by about two and a half decades.

And the calculation of life expectancy is more complex now, than ever.

According to a new study just published in the Journal of the American Medical Association, “inequalities in life expectancy among counties are large and growing, and much of the variation in life expectancy can be explained by differences in socioeconomic and race/ethnicity factors, behavioral and metabolic risk factors, and health care factors.”

And earlier studies have routinely shown that life expectancy in the United States varies geographically, in some cases dramatically. Between 1980 and 2014, life expectancy at birth for both sexes combined in the United States increased by 5.3%. This masks massive variation at the county level; counties in central Colorado, Alaska, and along both coasts experienced much larger increases, while some southern counties in states stretching from Oklahoma to West Virginia saw little, if any, improvement over this same period.

According to a 2010 report by the Los Angeles Times, Los Angeles County residents are living longer than ever, with an average life expectancy of more than 80 years according to public health officials. The average life expectancy in the county was 80.3 years. However Asian and Pacific Islander women had the longest average life expectancy, 86.9 years, while black men had the shortest, 69.4 years, according to the study.

Public health officials in Los Angeles examined life expectancy in 103 cities and unincorporated areas of the county with populations of more than 15,000. They also assessed each of the 15 Los Angeles City Council districts. Of the cities, La Canada Flintridge had the highest life expectancy, 87.8 years, while Compton had the lowest, 75.7 years.

And wait! There’s more!

Life expectancy is viewed differently by the annuity companies that underwrite the Medicare Set Aside Trusts in worker’s compensation cases. This estimate is often referred to as “rated age.” Every life insurance company has different underwriting guidelines that determine what risk class an individual qualifies for. The company will look at an applicant’s personal medical history, smoker status, height/weight profile, results of the medical exam, family medical history (e.g. cancer or heart disease before age 60 in the immediate family), motor vehicle record, and any hazardous activities they may participate in (such as aviation, scuba diving, drag racing, etc).

Thus, a more sophisticated approach to estimating the life expectancy of an injured worker may be a valuable tool for claims administrators as they reserve cases, and propose or reject settlement offers.

One-Third of New FDA Approved Drugs Unsafe

The Food and Drug Administration is under pressure to approve drugs faster, but researchers at the Yale School of Medicine found that nearly a third of those approved from 2001 through 2010 had major safety issues years after they were made widely available to patients.

Seventy-one of the 222 drugs approved in the first decade of the millennium were withdrawn, required a “black box” warning on side effects or warranted a safety announcement about new risks to the public, Dr. Joseph Ross, an associate professor of medicine at Yale School of Medicine and colleagues reported in the Journal of the American Medical Association . The study included safety actions through Feb. 28.

It took a median of 4.2 years after the drugs were approved for these safety concerns to come to light, the study found, and issues were more common among psychiatric drugs, biologic drugs, drugs that were granted “accelerated approval” and drugs that were approved near the regulatory deadline for approval.

Drugs ushered through the FDA’s accelerated approval process were among those that had higher rates of safety interventions. These approvals typically rely on surrogate endpoints, meaning that researchers measured something other than survival, such as tumor size, to determine whether the drugs worked.

“This [finding on surrogate endpoints] has the greatest relationship to policy today,” Ross says. “In the 21st Century Cures Act, there’s a push to have the FDA move to further support the use of surrogate markers … [but] they’re more likely to have concerns in the post-market setting.”

Former President Barack Obama signed the 21st Century Cures Act into law on Dec. 13. It offers ways to speed drug approval by pushing the FDA to consider different kinds of evidence beyond the three phases of traditional clinical trials. The new process has made some researchers worry that it will open the door for approvals of drugs that haven’t been adequately tested.

The FDA’s system for reporting drug- and device-related health problems is voluntary. The reports are not verified, and critics say this system is underutilized and filled with incomplete and late information. The FDA also monitors other available studies and reports to determine whether it needs to take action a particular drug.

FDA spokeswoman Angela Hoague said the agency is reviewing Ross’s findings.

“All too often, patients and clinicians mistakenly view FDA approval as [an] indication that a product is fully safe and effective,” said Dr. Caleb Alexander, co-director of the Johns Hopkins Center for Drug Safety and Effectiveness who did not work on the study. “Nothing could be further from the truth. We learn tremendous amounts about a product only once it’s on the market and only after use among a broad population.”

Drs. Sobol, Heric and Two Other Providers Suspended

The Department of Industrial Relations and its Division of Workers’ Compensation have suspended four more medical providers from participating in California’s workers’ compensation system. DWC Acting Administrative Director George Parisotto issued Orders of Suspension for two providers who had not appealed suspension notices issued in early April.

The complete list including these newly added names are on the DIR website.

Kenneth Johnson, a physician in Ladera Heights, was suspended based on a criminal conviction, his prior suspension from the Medicare program, and the loss of his professional license. Dr. Johnson was found guilty in February 2014 of federal charges for a $20 million scheme to defraud Medicare and Medi-Cal. Johnson pre-signed thousands of blank prescriptions that were used on fraudulent claims for anti-psychotic medications by Manor Medical Imaging in Glendale.

Raymond Severt, an orthopedic surgeon in Santa Rosa, was also suspended based on a criminal conviction related to his qualifications and duties as a service provider and the loss of his professional license. Severt was convicted in Marin Superior Court for attempted lewd acts on a minor under the age of 14, and the Medical Board of California revoked his license following the conviction.

Parisotto also issued Determinations and Orders upholding the suspension of two providers who had appealed their notices.

Philip Sobol, an orthopedic surgeon in Los Angeles, was suspended based on a criminal conviction involving fraud and abuse of the workers’ compensation system. Sobol pled guilty in November 2015 for participating in a kickback scheme at Pacific Hospital of Long Beach, illegally referring thousands of his patients for spinal surgeries. Sobol did not challenge the grounds for suspension, but argued in his appeal that he could not be suspended because his conviction predated the new law and also that DIR was required to use a different procedure to hear his appeal. Workers’ Compensation Administrative Law Judge (WCALJ) William E. Gunn, who heard the appeal, rejected both arguments.

Thomas M. Heric, a physician in Los Angeles, was suspended due to a criminal conviction and prior suspension from the Medicare program. Heric was convicted over a decade ago in Sacramento’s federal District Court for Medicare and Medicaid-related health care fraud, which also resulted in his suspension from those programs by the U.S. Department of Health and Human Services. WCALJ Robert Mays rejected Heric’s argument that his convictions did not fit within a legal definition of fraud or abuse.

AB 1244 (Gray and Daly) requires the DWC Administrative Director to suspend any medical provider, physician or practitioner from participating in the workers’ compensation system in cases in which one or more of the following is true:

– – The provider has been convicted of a crime involving fraud or abuse of the Medi-Cal or Medicare programs or the workers’ compensation system, fraud or abuse of a patient, or related types of misconduct;

– – The provider has been suspended due to fraud or abuse from the Medicare or Medicaid (including Medi-Cal) programs; or

– – The provider’s license or certificate to provide health care has been surrendered or revoked.

There are currently 23 providers suspended from California’s workers’ compensation system. Where the suspension is due to conviction of a covered crime, AB 1244 also provides for the suspended provider’s lien claims to be consolidated in a special lien proceeding and dismissed, unless it can be shown that the liens were unrelated to the criminal conduct.

Both of the providers who appealed their suspension have a significant volume of lien activity in the workers’ compensation system.

Dr. Sobol has nearly 6,000 active workers’ compensation liens with an estimated total claim value of more than $42.7 million.

Dr. Heric presents a different set of circumstances in that he became active in California’s workers’ compensation system after his federal conviction and suspension from the Medicare program. This is one of the scenarios that the Legislature wanted to stop when adopting AB 1244. Heric is currently being prosecuted in Orange County Superior Court for alleged involvement in a medical insurance fraud scheme with Sim Carlisle Hoffman and several associated businesses (People v. Sim Carlisle Hoffman, Better Sleeping Medical Center. Inc., et al., Orange County Superior Court No. 14CF0243). The liens of Hoffman and associated entities (estimated at over 1400 liens, with an aggregate claim value of more than $7 million) are currently stayed pursuant to the lien stay provision in SB 1160 (Mendoza), and would become subject to consolidation following a conviction for the crimes charged. Therefore, any liens filed by or on behalf of Dr. Heric are also subject to the stay provisions of Labor Code Section 4615.